StockData
Johnson & Johnson logo

Johnson & Johnson

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3042% above fair value
$270.56−2.64 (-0.97%)

Close on Nov 2, 2026Market cap $652.02BP/E 31.4Yield 1.90%

Johnson & Johnson Electrophysiology sub-franchise by Year

Electrophysiology sub-franchise — International operational growth YoY (%) (%)

Johnson & Johnson Electrophysiology sub-franchise: 7.3% in FY2025, down 9.7 pts from a year earlier.

Latest, FY2025
7.3%
Period ended Dec 28, 2025
Change on a year earlier
-9.7 pts
17.0% in FY2024
History
3 years
Since FY2023
Sources
3
Documents cited below

Where the FY2025 figure comes from

“|| Intl | 2,743 | 2,529 | 8.5 | 7.3 | 1.2”

Source: Form 8-K (a2025q4exhibit991.htm, filed 2026-01-21) ↗

Reported in Form 8-K EX-99.2 Segment Sales Schedule.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedElectrophysiology sub-franchise — International operational growth YoY (%) (%)Year on yearSource
FY2025Dec 28, 20257.3%-9.7 ptsForm 8-K (a2025q4exhibit991.htm, filed 2026-01-21) ↗
FY2024Dec 29, 202417.0%-4.5 ptsForm 8-K (a2024q4exhibit991.htm, filed 2025-01-22) ↗
FY2023Dec 31, 202321.5%–Form 8-K (a2023q4exhibit991.htm, filed 2024-01-23) ↗

Cite this data

StockData. (2026). Johnson & Johnson Electrophysiology sub-franchise (%), annual FY2023–FY2025 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/mt-electrophysiology-intl-ops-yoy

See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.